
NCBI . NLM . NIH . GOV {
}
Title[redir]:
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial - PMC
Description:
Patients with recurrent glioblastoma (rGB) have a poor prognosis with a median overall survival (OS) of 30–39 weeks in prospective clinical trials. Intravenous administration of programmed cell death protein 1 and cytotoxic T-lymphocyte-associated ...
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is ncbi.nlm.nih.gov built with?
Custom-built
No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of ncbi.nlm.nih.gov audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Ncbi.nlm.nih.gov Make Money? {💸}
The income method remains a mystery to us.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Ncbi.nlm.nih.gov has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
patients, glioblastoma, google, scholar, doi, nivolumab, pubmed, tumor, study, recurrent, resection, pmc, ipilimumab, treatment, phase, article, free, clinical, trial, patient, survival, cohort, brain, administration, combination, analysis, cells, therapy, tissue, data, cancer, intravenous, immune, treated, grade, weeks, progression, mab, dose, idh, oncol, expression, found, prior, checkpoint, median, pfs, temozolomide, compared, figure,
Topics {✒️}
methylated o6-methylguanine-dna methyltransferase cell-cycle-related gene expression gm-csf-expressing glioma cells ifn-γ-related gene expression o-6-methylguanine dna methyltransferase single-agent anti-programmed death-1 surgery+concomitant rt/tmz+adjuvant tmz data availability statements 18f-fet-pet/ct gadolinium-enhanced t1 mri data availability statement pmc beta search large-scale analysis reveals vaccination-induced immune response antitumor t-cell repertoire pan-tumor genomic biomarkers descriptive log-rank test small-cell lung cancer pmc copyright notice tumor pd-l1 expression gene expression profiling advanced renal-cell carcinoma median progression-free survival single agent anti-pd-1 immune-related adverse events b7-h3 expression score mgmt-promotor methylation status therapeutic monoclonal antibodies single-cell rna-sequencing pd-1-blocking mab pembrolizumab anti-pd-l1 mab anti-ctla-4 mab resulted shown pd-l1 expression ffpe-pretreated tumor biopsies postoperative gadolinium enhancement encouraging long-term os ctla-4-blocking mab ipilimumab [google scholar] 55 central nervous system low-cost immunotherapeutic backbone intratumoral anti-ctla-4 therapy pathogenic mutations detected gadolinium-enhanced mri gadolinium-enhanced lining prospective clinical trials progression-free survival high-throughput assay pd-l1 gep score immune checkpoint blockade recurrent high-grade gliomas
Questions {❓}
- Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Social Networks {👍}(6)
External Links {🔗}(129)
- How much does https://doi.org/10.1136/jitc-2020-002296 rake in every month?
- How much revenue does https://creativecommons.org/licenses/by-nc/4.0/ generate?
- See how much http://NCT03233152 makes per month
- How much does https://clinicaltrials.gov/ct2/show/NCT02667587 generate monthly?
- How much revenue does https://doi.org/10.1016/S1470-2045(09)70025-7 bring in?
- What's the income of https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&title=Effects%20of%20radiotherapy%20with%20concomitant%20and%20adjuvant%20temozolomide%20versus%20radiotherapy%20alone%20on%20survival%20in%20glioblastoma%20in%20a%20randomised%20phase%20III%20study:%205-year%20analysis%20of%20the%20EORTC-NCIC%20trial&volume=10&publication_year=2009&pages=459-66&pmid=19269895&doi=10.1016/S1470-2045(09)70025-7&?
- Find out how much https://doi.org/10.1056/NEJMoa1707358 earns monthly
- How much does https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Lomustine%20and%20bevacizumab%20in%20progressive%20glioblastoma&volume=377&publication_year=2017&pages=1954-63&pmid=29141164&doi=10.1056/NEJMoa1707358& earn?
- What's the income generated by https://doi.org/10.1200/JCO.2012.47.2464 each month?
- Monthly income for https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Phase%20III%20randomized%20trial%20comparing%20the%20efficacy%20of%20cediranib%20as%20monotherapy,%20and%20in%20combination%20with%20lomustine,%20versus%20lomustine%20alone%20in%20patients%20with%20recurrent%20glioblastoma&volume=31&publication_year=2013&pages=3212-8&pmid=23940216&doi=10.1200/JCO.2012.47.2464&
- What's the financial intake of https://doi.org/10.1200/JCO.1999.17.8.2572?
- What's https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Outcomes%20and%20prognostic%20factors%20in%20recurrent%20glioma%20patients%20enrolled%20onto%20phase%20II%20clinical%20trials&volume=17&publication_year=1999&pages=2572-8&pmid=10561324&doi=10.1200/JCO.1999.17.8.2572&'s gross income?
- How much does https://doi.org/10.1215/15228517-2007-062 rake in every month?
- What's the monthly income of https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&title=Progression-Free%20survival:%20an%20important%20end%20point%20in%20evaluating%20therapy%20for%20recurrent%20high-grade%20gliomas&volume=10&publication_year=2008&pages=162-70&pmid=18356283&doi=10.1215/15228517-2007-062&?
- How much income does https://doi.org/10.3171/2013.12.JNS13184 have?
- See how much https://scholar.google.com/scholar_lookup?journal=J%20Neurosurg&title=An%20extent%20of%20resection%20threshold%20for%20recurrent%20glioblastoma%20and%20its%20risk%20for%20neurological%20morbidity&volume=120&publication_year=2014&pages=846-53&pmid=24484232&doi=10.3171/2013.12.JNS13184& makes per month
- How much profit does https://doi.org/10.1093/neuonc/nov145 generate?
- How much money does https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&title=Clinical%20benefit%20from%20resection%20of%20recurrent%20glioblastomas:%20results%20of%20a%20multicenter%20study%20including%20503%20patients%20with%20recurrent%20glioblastomas%20undergoing%20surgical%20resection&volume=18&publication_year=2016&pages=96-104&pmid=26243790&doi=10.1093/neuonc/nov145& generate?
- What's the financial gain of https://doi.org/10.3171/2012.9.JNS12504?
- Profit of https://scholar.google.com/scholar_lookup?journal=J%20Neurosurg&title=Impact%20of%20extent%20of%20resection%20for%20recurrent%20glioblastoma%20on%20overall%20survival:%20clinical%20article&volume=117&publication_year=2012&pages=1032-8&pmid=23039151&doi=10.3171/2012.9.JNS12504&
- What are the earnings of https://doi.org/10.1093/neuonc/nor110?
- How profitable is https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&title=Is%20surgery%20at%20progression%20a%20prognostic%20marker%20for%20improved%206-month%20progression-free%20survival%20or%20overall%20survival%20for%20patients%20with%20recurrent%20glioblastoma?&volume=13&publication_year=2011&pages=1118-24&pmid=21813511&doi=10.1093/neuonc/nor110&?
- What's the financial gain of https://doi.org/10.1126/science.aar4060?
- How much does https://scholar.google.com/scholar_lookup?journal=Science&title=Cancer%20immunotherapy%20using%20checkpoint%20blockade&volume=359&publication_year=2018&pages=1350-5&pmid=29567705&doi=10.1126/science.aar4060& generate monthly?
- See how much https://doi.org/10.1097/CJI.0b013e3182562d59 makes per month
- What's the revenue for https://scholar.google.com/scholar_lookup?journal=J%20Immunother&title=Sequential%20immunotherapy%20by%20vaccination%20with%20GM-CSF-expressing%20glioma%20cells%20and%20CTLA-4%20blockade%20effectively%20treats%20established%20murine%20intracranial%20tumors&volume=35&publication_year=2012&pages=385-9&pmid=22576343&doi=10.1097/CJI.0b013e3182562d59&?
- What's the monthly money flow for https://doi.org/10.1158/1078-0432.CCR-06-2070?
- Learn how profitable https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Systemic%20CTLA-4%20blockade%20ameliorates%20glioma-induced%20changes%20to%20the%20CD4+%20T%20cell%20compartment%20without%20affecting%20regulatory%20T-cell%20function&volume=13&publication_year=2007&pages=2158-67&pmid=17404100&doi=10.1158/1078-0432.CCR-06-2070& is on a monthly basis
- How much does https://doi.org/10.1172/jci.insight.87059 gross monthly?
- What's the financial intake of https://scholar.google.com/scholar_lookup?journal=JCI%20Insight&title=Pd-1%20blockade%20enhances%20the%20vaccination-induced%20immune%20response%20in%20glioma&volume=1&publication_year=2016&pmid=27453950&doi=10.1172/jci.insight.87059&?
- What's the financial outcome of https://doi.org/10.1158/2326-6066.CIR-15-0151?
- Learn about the earnings of https://scholar.google.com/scholar_lookup?journal=Cancer%20Immunol%20Res&title=Glioblastoma%20eradication%20following%20immune%20checkpoint%20blockade%20in%20an%20orthotopic,%20immunocompetent%20model&volume=4&publication_year=2016&pages=124-35&pmid=26546453&doi=10.1158/2326-6066.CIR-15-0151&
- How much income is https://doi.org/10.1158/1078-0432.CCR-14-0514 earning monthly?
- How much profit is https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Durable%20therapeutic%20efficacy%20utilizing%20combinatorial%20blockade%20against%20IDO,%20CTLA-4,%20and%20PD-L1%20in%20mice%20with%20brain%20tumors&volume=20&publication_year=2014&pages=5290-301&pmid=24691018&doi=10.1158/1078-0432.CCR-14-0514& making per month?
- What's the financial gain of https://doi.org/10.1016/j.ijrobp.2012.12.025?
- How much does https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&title=Anti-PD-1%20blockade%20and%20stereotactic%20radiation%20produce%20long-term%20survival%20in%20mice%20with%20intracranial%20gliomas&volume=86&publication_year=2013&pages=343-9&pmid=23462419&doi=10.1016/j.ijrobp.2012.12.025& rake in every month?
- https://doi.org/10.1158/1078-0432.CCR-15-1535's financial summary
- Discover the revenue of https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Combination%20therapy%20with%20anti-PD-1,%20Anti-TIM-3,%20and%20focal%20radiation%20results%20in%20regression%20of%20murine%20gliomas&volume=23&publication_year=2017&pages=124-36&pmid=27358487&doi=10.1158/1078-0432.CCR-15-1535&
- What is the monthly revenue of https://doi.org/10.1093/neuonc/nox208?
- Monthly income for https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&title=Nivolumab%20with%20or%20without%20ipilimumab%20in%20patients%20with%20recurrent%20glioblastoma:%20results%20from%20exploratory%20phase%20I%20cohorts%20of%20CheckMate%20143&volume=20&publication_year=2018&pages=674-86&pmid=29106665&doi=10.1093/neuonc/nox208&
- How much profit does https://doi.org/10.1001/jamaoncol.2020.1024 make?
- What's the profit of https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&title=Effect%20of%20nivolumab%20vs%20bevacizumab%20in%20patients%20with%20recurrent%20glioblastoma:%20the%20CheckMate%20143%20phase%203%20randomized%20clinical%20trial&volume=6&publication_year=2020&pages=1003-1010&pmid=32437507&doi=10.1001/jamaoncol.2020.1024&?
- Check the income stats for https://doi.org/10.1007/s11060-016-2190-1
- https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&title=Pembrolizumab:%20first%20experience%20with%20recurrent%20primary%20central%20nervous%20system%20(CNS)%20tumors&volume=129&publication_year=2016&pages=453-60&pmid=27377654&doi=10.1007/s11060-016-2190-1&'s revenue stream
- How much money does https://doi.org/10.1200/JCO.2018.36.15_suppl.2006 generate?
- Profit of https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&title=Phase%20II%20study%20of%20pembrolizumab%20or%20pembrolizumab%20plus%20bevacizumab%20for%20recurrent%20glioblastoma%20(rGBM)%20patients&volume=36&publication_year=2018&pages=2006-06&doi=10.1200/JCO.2018.36.15_suppl.2006&
- How much revenue does https://doi.org/10.1200/JCO.2016.34.15_suppl.TPS2079 bring in?
- How much does https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&title=A%20randomized,%20phase%203,%20open-label%20study%20of%20nivolumab%20versus%20temozolomide%20(TMZ)%20in%20combination%20with%20radiotherapy%20(RT)%20in%20adult%20patients%20(pts)%20with%20newly%20diagnosed,%20O-6-methylguanine%20DNA%20methyltransferase%20(MGMT)-unmethylated%20glioblastoma%20(GBM):%20CheckMate-498&volume=34&publication_year=2016&pages=TPS2079-TPS79&doi=10.1200/JCO.2016.34.15_suppl.TPS2079& earn?
- What are the total earnings of https://doi.org/10.1126/science.aar3593?
- https://scholar.google.com/scholar_lookup?journal=Science&title=Pan-tumor%20genomic%20biomarkers%20for%20PD-1%20checkpoint%20blockade-based%20immunotherapy&volume=362&publication_year=2018&pmid=30309915&doi=10.1126/science.aar3593&'s revenue stream
- https://doi.org/10.1038/s41568-019-0224-7's revenue stream
- Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&title=Brain%20immunology%20and%20immunotherapy%20in%20brain%20tumours&volume=20&publication_year=2020&pages=12-25&pmid=31806885&doi=10.1038/s41568-019-0224-7&
- Learn how profitable https://doi.org/10.1200/JCO.2016.66.6552 is on a monthly basis
- Check the income stats for https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Immune%20checkpoint%20inhibition%20for%20Hypermutant%20glioblastoma%20multiforme%20resulting%20from%20germline%20biallelic%20mismatch%20repair%20deficiency&volume=34&publication_year=2016&pages=2206-11&pmid=27001570&doi=10.1200/JCO.2016.66.6552&
- Get to know https://doi.org/10.1056/NEJMoa1805453's earnings
- How much profit is https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Combined%20nivolumab%20and%20ipilimumab%20in%20melanoma%20metastatic%20to%20the%20brain&volume=379&publication_year=2018&pages=722-30&pmid=30134131&doi=10.1056/NEJMoa1805453& making per month?
- Find out how much https://doi.org/10.1038/s41591-018-0135-2 earns monthly
- Get to know https://scholar.google.com/scholar_lookup?journal=Nat%20Med&title=Sequestration%20of%20T%20cells%20in%20bone%20marrow%20in%20the%20setting%20of%20glioblastoma%20and%20other%20intracranial%20tumors&volume=24&publication_year=2018&pages=1459-68&pmid=30104766&doi=10.1038/s41591-018-0135-2&'s earnings
- https://doi.org/10.1158/1078-0432.CCR-17-2617's total income per month
- What's the total monthly financial gain of https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Immunophenotyping%20of%20newly%20diagnosed%20and%20recurrent%20glioblastoma%20defines%20distinct%20immune%20exhaustion%20profiles%20in%20peripheral%20and%20tumor-infiltrating%20lymphocytes&volume=24&publication_year=2018&pages=4187-200&pmid=29444930&doi=10.1158/1078-0432.CCR-17-2617&?
- What's the financial outcome of https://doi.org/10.1093/neuonc/noz185?
- What's https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&title=Window-of-opportunity%20clinical%20trial%20of%20pembrolizumab%20in%20patients%20with%20recurrent%20glioblastoma%20reveals%20predominance%20of%20immune-suppressive%20macrophages&volume=22&publication_year=2020&pages=539-49&pmid=31755915&doi=10.1093/neuonc/noz185&'s gross income?
- How much does https://doi.org/10.1038/s41591-018-0337-7 rake in every month?
- What's the monthly income of https://scholar.google.com/scholar_lookup?journal=Nat%20Med&title=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma&volume=25&publication_year=2019&pages=477-86&pmid=30742122&doi=10.1038/s41591-018-0337-7&?
- How much does https://doi.org/10.1038/s41591-018-0339-5 pull in monthly?
- How much money does https://scholar.google.com/scholar_lookup?journal=Nat%20Med&title=Neoadjuvant%20nivolumab%20modifies%20the%20tumor%20immune%20microenvironment%20in%20resectable%20glioblastoma&volume=25&publication_year=2019&pages=470-6&pmid=30742120&doi=10.1038/s41591-018-0339-5& generate?
- How much money does https://doi.org/10.1158/1078-0432.CCR-13-1923 generate?
- https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Intratumoral%20anti-CTLA-4%20therapy:%20enhancing%20efficacy%20while%20avoiding%20toxicity&volume=19&publication_year=2013&pages=5261-3&pmid=23965900&doi=10.1158/1078-0432.CCR-13-1923&'s revenue stream
- How much does https://doi.org/10.1158/1078-0432.CCR-12-0781 earn?
- How much money does https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Controlled%20local%20delivery%20of%20CTLA-4%20blocking%20antibody%20induces%20CD8+%20T-cell-dependent%20tumor%20eradication%20and%20decreases%20risk%20of%20toxic%20side%20effects&volume=19&publication_year=2013&pages=5381-9&pmid=23788581&doi=10.1158/1078-0432.CCR-12-0781& make?
- Get to know https://doi.org/10.18632/oncotarget.10453's earnings
- What's the revenue for https://scholar.google.com/scholar_lookup?journal=Oncotarget&title=A%20phase%20I%20study%20of%20intratumoral%20ipilimumab%20and%20interleukin-2%20in%20patients%20with%20advanced%20melanoma&volume=7&publication_year=2016&pages=64390-64399&pmid=27391442&doi=10.18632/oncotarget.10453&?
- What's the profit of https://doi.org/10.1093/annonc/mdy485.011?
- What's the monthly income of https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Oncology&title=A%20phase%20I%20clinical%20trial%20on%20intratumoral%20administration%20of%20autologous%20CD1c%20(BDCA-1)+%20myeloid%20dendritic%20cells%20(myDC)%20in%20combination%20with%20ipilimumab%20(IPI)%20and%20avelumab%20(AVE)%20plus%20intravenous%20low-dose%20nivolumab%20(NIVO)%20in%20patients%20with%20advanced%20solid%20tumors&volume=29&publication_year=2018&pages=x14&pmid=33182610&doi=10.1093/annonc/mdy485.011&?
- What's the income of https://doi.org/10.2353/jmoldx.2006.050135?
- What's the income generated by https://scholar.google.com/scholar_lookup?journal=J%20Mol%20Diagn&title=Precision%20and%20performance%20characteristics%20of%20bisulfite%20conversion%20and%20real-time%20PCR%20(MethyLight)%20for%20quantitative%20DNA%20methylation%20analysis&volume=8&publication_year=2006&pages=209-17&pmid=16645207&doi=10.2353/jmoldx.2006.050135& each month?
- What's the monthly income of https://doi.org/10.1093/nar/28.8.e32?
- What's the monthly money flow for https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&title=MethyLight:%20a%20high-throughput%20assay%20to%20measure%20DNA%20methylation&volume=28&publication_year=2000&pages=E32&pmid=10734209&doi=10.1093/nar/28.8.e32&?
- Get to know https://doi.org/10.3390/cancers11122030's earnings
- Revenue of https://scholar.google.com/scholar_lookup?journal=Cancers&title=Standardization%20of%20somatic%20variant%20classifications%20in%20solid%20and%20haematological%20tumours%20by%20a%20two-level%20approach%20of%20biological%20and%20clinical%20classes:%20an%20initiative%20of%20the%20Belgian%20ComPerMed%20expert%20panel&volume=11&publication_year=2019&pmid=31888289&doi=10.3390/cancers11122030&
- How much profit does https://doi.org/10.1007/s00415-014-7633-z make?
- How profitable is https://scholar.google.com/scholar_lookup?journal=J%20Neurol&title=Patient%20outcome%20in%20the%20Belgian%20medical%20need%20program%20on%20bevacizumab%20for%20recurrent%20glioblastoma&volume=262&publication_year=2015&pages=742-51&pmid=25572162&doi=10.1007/s00415-014-7633-z&?
- What are the earnings of https://doi.org/10.1007/s11060-017-2629-z?
- How much does https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&title=Randomized%20phase%20II%20trial%20comparing%20axitinib%20with%20the%20combination%20of%20axitinib%20and%20lomustine%20in%20patients%20with%20recurrent%20glioblastoma&volume=136&publication_year=2018&pages=115-25&pmid=28988341&doi=10.1007/s11060-017-2629-z& earn?
- Explore the financials of https://doi.org/10.1007/s11060-016-2092-2
- What's the income generated by https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&title=Randomized%20phase%20II%20study%20of%20axitinib%20versus%20physicians%20best%20alternative%20choice%20of%20therapy%20in%20patients%20with%20recurrent%20glioblastoma&volume=128&publication_year=2016&pages=147-55&pmid=26935577&doi=10.1007/s11060-016-2092-2& each month?
- How much profit is https://doi.org/10.1136/jitc-2020-001146 making per month?
- What's the monthly money flow for https://scholar.google.com/scholar_lookup?journal=J%20Immunother%20Cancer&title=Axitinib%20plus%20avelumab%20in%20the%20treatment%20of%20recurrent%20glioblastoma:%20a%20stratified,%20open-label,%20single-center%20phase%202%20clinical%20trial%20(GliAvAx)&volume=8&publication_year=2020&pages=e001146&pmid=33067319&doi=10.1136/jitc-2020-001146&?
- What's the income of https://doi.org/10.1056/NEJMoa1801946?
- Income figures for https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Nivolumab%20plus%20ipilimumab%20in%20lung%20cancer%20with%20a%20high%20tumor%20mutational%20burden&volume=378&publication_year=2018&pages=2093-104&pmid=29658845&doi=10.1056/NEJMoa1801946&
- How much money does https://doi.org/10.1056/NEJMoa1910231 make?
- How much money does https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Nivolumab%20plus%20ipilimumab%20in%20advanced%20non-small-cell%20lung%20cancer&volume=381&publication_year=2019&pages=2020-31&pmid=31562796&doi=10.1056/NEJMoa1910231& generate?
- How much money does https://doi.org/10.1056/NEJMoa1910836 make?
- What's https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Five-Year%20survival%20with%20combined%20nivolumab%20and%20ipilimumab%20in%20advanced%20melanoma&volume=381&publication_year=2019&pages=1535-46&pmid=31562797&doi=10.1056/NEJMoa1910836&'s gross income?
- Discover the revenue of https://doi.org/10.1056/NEJMoa1712126
- What are the total earnings of https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Nivolumab%20plus%20ipilimumab%20versus%20sunitinib%20in%20advanced%20renal-cell%20carcinoma&volume=378&publication_year=2018&pages=1277-90&pmid=29562145&doi=10.1056/NEJMoa1712126&?
- What is the earnings of https://doi.org/10.1016/S1470-2045(18)30765-4?
- How much does https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&title=Nivolumab%20or%20nivolumab%20plus%20ipilimumab%20in%20patients%20with%20relapsed%20malignant%20pleural%20mesothelioma%20(IFCT-1501%20MAPS2):%20a%20multicentre,%20open-label,%20randomised,%20non-comparative,%20phase%202%20trial&volume=20&publication_year=2019&pages=239-53&pmid=30660609&doi=10.1016/S1470-2045(18)30765-4& gross monthly?
- How much cash flow does https://doi.org/10.1001/jamaoncol.2020.4564 have monthly?
- How much does https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&title=Efficacy%20and%20safety%20of%20nivolumab%20plus%20ipilimumab%20in%20patients%20with%20advanced%20hepatocellular%20carcinoma%20previously%20treated%20with%20sorafenib:%20the%20CheckMate%20040%20randomized%20clinical%20trial&volume=6&publication_year=2020&pages=e204564&pmid=33001135&doi=10.1001/jamaoncol.2020.4564& pull in?
- What's the financial gain of https://doi.org/10.1200/JCO.2017.76.9901?
- https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Durable%20clinical%20benefit%20with%20nivolumab%20plus%20ipilimumab%20in%20DNA%20mismatch%20Repair-Deficient/Microsatellite%20Instability-High%20metastatic%20colorectal%20cancer&volume=36&publication_year=2018&pages=773-9&pmid=29355075&doi=10.1200/JCO.2017.76.9901&'s financial summary
- How much does http://dx.doi.org/Alexandria,Virginia net monthly?
- Revenue of https://scholar.google.com/scholar_lookup?title=A%20sequential%20dual%20cohort%20phase%20II%20clinical%20trial%20on%20adjuvant%20low-dose%20nivolumab%20with%20or%20without%20low-dose%20ipilimumab%20as%20adjuvant%20therapy%20following%20the%20resection%20of%20melanoma%20macrometastases%20(Mm)%20ASCO%20annual%20meeting&publication_year=2019&
- What's the profit of https://doi.org/10.1200/JCO.2013.53.0105?
- How much money does https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Survival,%20durable%20tumor%20remission,%20and%20long-term%20safety%20in%20patients%20with%20advanced%20melanoma%20receiving%20nivolumab&volume=32&publication_year=2014&pages=1020-30&pmid=24590637&doi=10.1200/JCO.2013.53.0105& make?
- What are the earnings of https://doi.org/10.1200/JCO.2009.26.7609?
- What's the monthly income of https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Phase%20I%20study%20of%20single-agent%20anti-programmed%20death-1%20(MDX-1106)%20in%20refractory%20solid%20tumors:%20safety,%20clinical%20activity,%20pharmacodynamics,%20and%20immunologic%20correlates&volume=28&publication_year=2010&pages=3167-75&pmid=20516446&doi=10.1200/JCO.2009.26.7609&?
- How much income does https://doi.org/10.1093/annonc/mdy289.057 have?
- Explore the financials of https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Oncology&title=A%20phase%20I/Ib%20study%20of%20concurrent%20intravenous%20(IV)%20and%20intrathecal%20(it)%20nivolumab%20(Nivo)%20for%20melanoma%20patients%20(PTS)%20with%20leptomeningeal%20disease%20(LMD)&volume=29&publication_year=2018&pages=viii464&doi=10.1093/annonc/mdy289.057&
- How much profit is https://scholar.google.com/scholar_lookup?title=A%20phase%20I%20clinical%20trial%20on%20intratumoral%20and%20intracavitary%20administration%20of%20ipilimumab%20and%20nivolumab%20in%20patients%20with%20recurrent%20glioblastoma;%20ASCO%20virtual%20scientific%20program&publication_year=2020& making per month?
- How much does https://doi.org/10.3390/vaccines8040670 gross monthly?
- Revenue of https://scholar.google.com/scholar_lookup?journal=Vaccines&title=Intratumoral%20Combinatorial%20Administration%20of%20CD1c%20(BDCA-1)+%20Myeloid%20Dendritic%20Cells%20Plus%20Ipilimumab%20and%20Avelumab%20in%20Combination%20with%20Intravenous%20Low-Dose%20Nivolumab%20in%20Patients%20with%20Advanced%20Solid%20Tumors:%20A%20Phase%20IB%20Clinical%20Trial&volume=8&publication_year=2020&pmid=33182610&doi=10.3390/vaccines8040670&
- What are the total earnings of https://doi.org/10.1080/2162402X.2018.1461304?
- Revenue of https://scholar.google.com/scholar_lookup?journal=Oncoimmunology&title=Large-Scale%20analysis%20reveals%20the%20specific%20clinical%20and%20immune%20features%20of%20B7-H3%20in%20glioma&volume=7&publication_year=2018&pages=e1461304&pmid=30377558&doi=10.1080/2162402X.2018.1461304&
- What is the earnings of https://doi.org/10.7150/ijbs.41105?
- How much revenue does https://scholar.google.com/scholar_lookup?journal=Int%20J%20Biol%20Sci&title=B7-H3,%20a%20checkpoint%20molecule,%20as%20a%20target%20for%20cancer%20immunotherapy&volume=16&publication_year=2020&pages=1767-73&pmid=32398947&doi=10.7150/ijbs.41105& generate?
- How much does https://github.com/ncbi generate monthly?
- https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323's revenue stream
- How profitable is https://www.nlm.nih.gov/web_policies.html?
- See how much https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office makes per month
- Find out how much https://www.hhs.gov/vulnerability-disclosure-policy/index.html earns monthly
- How much does https://support.nlm.nih.gov/?pagename=cloudpmc-viewer%3Apmc%3Aarticle%3Ajournal bring in each month?
- Income figures for https://www.nlm.nih.gov/accessibility.html
- How much income is https://www.nlm.nih.gov/careers/careers.html earning monthly?
- What's the financial intake of https://www.nlm.nih.gov/?
- Get to know what's the income of https://www.nih.gov/
- https://www.hhs.gov/'s revenue stream
- What is the earnings of https://www.usa.gov/?
Analytics and Tracking {📊}
- Google Analytics
- Google Analytics 4
- Google Tag Manager
Libraries {📚}
- jQuery
- jQuery module (jquery-3.6.0)
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- nihcesxway.hub.nih.gov
- nihcesxway2.hub.nih.gov
- nihcesxway3.hub.nih.gov
- nihcesxway4.hub.nih.gov
- nihcesxway5.hub.nih.gov
Name Servers:
- dns1-ncbi.ncbi.nlm.nih.gov
- dns2-ncbi.ncbi.nlm.nih.gov
- lhcns1.nlm.nih.gov
- lhcns2.nlm.nih.gov
CDN Services {📦}
- Ncbi